CONSISTENT LOW-DENSITY LIPOPROTEIN CHOLESTEROL LOWERING EFFICACY OF ALIROCUMAB IN HIGH AND VERY HIGH CARDIOVASCULAR RISK PATIENTS WITH LOW-DENSITY LIPOPROTEIN CHOLESTEROL >100/70 MG/DL AT BASELINE
2017 ◽
Vol 69
(11)
◽
pp. 1712
2018 ◽
Vol 71
(11)
◽
pp. A1767
2016 ◽
Vol 67
(13)
◽
pp. 2034
2018 ◽
Vol Volume 13
◽
pp. 9-19
◽
2010 ◽
Vol 17
(2)
◽
pp. 167-175
◽
2021 ◽
Vol 28
(1)
◽
pp. 79-89
◽
2018 ◽
Vol 71
(11)
◽
pp. A1445
◽